Results 121 to 130 of about 26,466 (239)

Practical Approach to Reporting Based on the International System for Serous Fluid Cytopathology

The International System for Serous Fluid Cytopathology (TIS) is intended for reporting cytological specimens from serous cavities: pleural, abdominal and pericardial cavities. TIS is being adopted into practice in cytology laboratories worldwide.
Viljanen, Eliisa, Kholová, Ivana, Chandra, Ashish   +2 more
core   +1 more source

Economic value and clinical role of minimally invasive, biopsy‐based diagnostics in non‐small cell lung cancer

Cancer Cytopathology, Volume 134, Issue 10, October 2026.
Abstract Background Precision oncology requires diagnostic sampling that delivers molecularly actionable material quickly and safely. In non‐small cell lung cancer (NSCLC), core‐needle biopsy (CNB) remains common. Yet fine‐needle aspiration (FNA) has re‐emerged with rapid on‐site evaluation (ROSE), optimized cell blocks, and next‐generation sequencing.
Jiayuan Guo, Bo Franzén, Rolf Lewensohn, Martin Hysek, Linus Jönsson   +4 more
wiley   +1 more source

Spotlight: Rising stars in cytology. [PDF]

Cancer Cytopathol
O'Conor C.
europepmc   +3 more sources

Touch imprint cytological diagnosis of nodal Langerhans Cell Histiocytosis

B-ENT, 2009
Touch imprint cytological diagnosis of nodal Langerhans cell histiocytosis. Langerhans cell histiocytosis (LCH) is a rare neoplasm of the mononuclear phagocytic immunoregulatory system of unknown aetiology. Nodal involvement is uncommon.
D. Tamiolakis, S. Barbagadaki, E. Proimos, S. Nikolaidou, T. S. Chimona, G. Georgiou, G. Perogamvrakis, C. E. Papadakis   +7 more
doaj   +2 more sources

Parsing the thyroid cytopathology suspicious for malignancy diagnosis through molecular‐derived risk of malignancy and other related parameters: Insights into nodule characteristics and practice patterns

Introduction Thyroid cytopathology cases with suspicious for malignancy (SFM) diagnosis often result in resection. However, molecular testing offers details that may provide additional insights. In this study, the molecular profiles of SFM cases from two
Nikiforov, Yuri E., Ohori, N. Paul, Starr, David, Gomez-Fernandez, Carmen, Karslioglu-French, Esra, Carty, Sally E., Tjendra, Youley, Yip, Linwah, Velez Torres, Jaylou M., Seethala, Raja R., Khader, Samer N., Skaugen, John M.   +11 more
core   +1 more source

Half of metastatic CSCC arises from low‐stage primaries: A nationwide analysis

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Loes. M. Hollestein, Antien. L. Mooyaart, Olivia Frederique Maria Steijlen, Andrya Reder Hollatz, Meggie M. C. M. Drissen, Marieke Louwman, Marlies Wakkee   +6 more
wiley   +1 more source

What Is Your Diagnosis? Superficial Cervical Lymph Node Cytology

Veterinary Clinical Pathology, EarlyView.
Vinicius N. Hirata, Rúbia S. da Silva, Francisca B. Lang, Augusto de Oliveira, Cinthia M. de Andrade   +4 more
wiley   +1 more source

Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer

MedComm, Volume 7, Issue 10, October 2026.
Mesothelin overexpression activate important pathways like nuclear factor k‐light‐chain‐enhancer of activated B cells (NF‐κB) and interleukin‐6 (IL‐6). This in turn causes numerous cancers, such as pancreatic and ovarian cancers. MSLN‐targeting immunotherapies, like monoclonal antibodies, have shown efficacy.
Manoj Kumar Gupta, Ramakrishna Vadde, Ganji Purnachandra Nagaraju   +2 more
wiley   +1 more source

A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?

, 2015
A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been ...
Rossi, Esther, Damiani, Domenico, Chiara Brunelli, Cianfrini, Federica, Fadda, Guido, Tommaso Bizzarro, Esther Diana Rossi, Straccia, Patrizia, Guido Fadda, Domenico Damiani, Patrizia Straccia, Bizzarro, Tommaso, Federica Cianfrini, Brunelli, Chiara   +13 more
core   +1 more source

Loss to follow‐up in patients diagnosed with or treated for low‐ and high‐grade squamous intraepithelial lesions: A comparison of general practitioner‐ and gynecologist‐led surveillance

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 2081-2088, October 2026.
Follow‐up by general practitioners after LSIL or treated HSIL was associated with higher loss to follow‐up rates compared with gynecologist‐led care. Loss to follow‐up was 38.1% versus 16.6% for LSIL at 12 months and 44.3% versus 24.1% for treated HSIL at 24 months.
Lieke van de Kam, Albert Siebers, Ruud Bekkers, Dennis van Hamont, Jurgen Piek   +4 more
wiley   +1 more source